Drug Insights

Effortless Searching: How to Find Pregabalin on Synapse

22 February 2024
2 min read

Pregabalin, commonly referred to as Lyrica®, is a well-known anticonvulsant medication, which has found its footing in the treatment of various medical conditions. Such conditions include but are not limited to anxiety disorders, epilepsy, and neuralgia. The mechanism of action that characterizes pregabalin's utility involves blocking the CACNA2D1 and CACNA2D2 calcium channels, thus effectively targeting these disorders with aplomb. The Upjohn Co. received approval for the medical use of pregabalin in the European Union as far back as 2004, indicating that the medication has been a key feature of medical treatment for some time. Pregabalin's indications primarily target the treatment of neuropathic pain conditions, including fibromyalgia, and partial onset seizures in combination with other anticonvulsant medications. These conditions are managed with pregabalin due to its efficacy in minimizing their attendant symptoms. Pregabalin, therefore, serves as a vital tool in the management of chronic pain and neurological disorders. Click on the image below to begin the exploration journey of Pregabalin through the Synapse database!

图形用户界面, 应用程序, 电子邮件

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

First Participant Receives Initial Dose of RP-1664 in Repare Therapeutics' Early-Stage Study
Latest Hotspot
3 min read
First Participant Receives Initial Dose of RP-1664 in Repare Therapeutics' Early-Stage Study
22 February 2024
Repare Therapeutics Inc. announced the first patient has been treated in their LIONS Phase 1 trial, focusing on RP-1664 – a leading oral inhibitor targeting polo-like kinase 4, intended for solo therapy.
Read →
Making the Most Out of Synapse: Searching for Topiramate
Drug Insights
2 min read
Making the Most Out of Synapse: Searching for Topiramate
22 February 2024
Topiramate, marketed under the trade name Topamax ®, is an anticonvulsant drug that was first approved in 1995 in the UK by Janssen Services.
Read →
Nuvig Launches Early Stage Trials for Advanced Immunomodulator NVG-2089
Latest Hotspot
3 min read
Nuvig Launches Early Stage Trials for Advanced Immunomodulator NVG-2089
22 February 2024
Nuvig Therapeutics, Inc., initiates first human trial of NVG-2089 for treating inflammatory myopathies and severe autoimmune skin diseases.
Read →
Synapse Simplified: How to Find Allopurinol Information
Drug Insights
2 min read
Synapse Simplified: How to Find Allopurinol Information
22 February 2024
Allopurinol, sold as Zyloprim®, is a drug that reduces uric acid in gout, kidney stones, and some cancers.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.